131 related articles for article (PubMed ID: 7932546)
21. Structure-based design of HIV-1 protease inhibitors: replacement of two amides and a 10 pi-aromatic system by a fused bis-tetrahydrofuran.
Ghosh AK; Thompson WJ; Fitzgerald PM; Culberson JC; Axel MG; McKee SP; Huff JR; Anderson PS
J Med Chem; 1994 Aug; 37(16):2506-8. PubMed ID: 8057296
[No Abstract] [Full Text] [Related]
22. 4-hydroxy-5,6-dihydropyrones. 2. Potent non-peptide inhibitors of HIV protease.
Tait BD; Hagen S; Domagala J; Ellsworth EL; Gajda C; Hamilton HW; Prasad JV; Ferguson D; Graham N; Hupe D; Nouhan C; Tummino PJ; Humblet C; Lunney EA; Pavlovsky A; Rubin J; Gracheck SJ; Baldwin ET; Bhat TN; Erickson JW; Gulnik SV; Liu B
J Med Chem; 1997 Nov; 40(23):3781-92. PubMed ID: 9371244
[TBL] [Abstract][Full Text] [Related]
23. Hydroxyquinones are competitive non-peptide inhibitors of HIV-1 proteinase.
Brinkworth RI; Fairlie DP
Biochim Biophys Acta; 1995 Nov; 1253(1):5-8. PubMed ID: 7492599
[TBL] [Abstract][Full Text] [Related]
24. Neutron crystallography used to identify targets to improve HIV-1 protease inhibitor.
Hill R
Future Med Chem; 2013 Oct; 5(15):1705. PubMed ID: 24144407
[No Abstract] [Full Text] [Related]
25. Structure-based design of nonpeptidic HIV protease inhibitors: the sulfonamide-substituted cyclooctylpyramones.
Skulnick HI; Johnson PD; Aristoff PA; Morris JK; Lovasz KD; Howe WJ; Watenpaugh KD; Janakiraman MN; Anderson DJ; Reischer RJ; Schwartz TM; Banitt LS; Tomich PK; Lynn JC; Horng MM; Chong KT; Hinshaw RR; Dolak LA; Seest EP; Schwende FJ; Rush BD; Howard GM; Toth LN; Wilkinson KR; Romines KR
J Med Chem; 1997 Mar; 40(7):1149-64. PubMed ID: 9089336
[TBL] [Abstract][Full Text] [Related]
26. X-ray crystallographic studies of a series of penicillin-derived asymmetric inhibitors of HIV-1 protease.
Jhoti H; Singh OM; Weir MP; Cooke R; Murray-Rust P; Wonacott A
Biochemistry; 1994 Jul; 33(28):8417-27. PubMed ID: 8031777
[TBL] [Abstract][Full Text] [Related]
27. Structure-based design of HIV protease inhibitors: sulfonamide-containing 5,6-dihydro-4-hydroxy-2-pyrones as non-peptidic inhibitors.
Thaisrivongs S; Skulnick HI; Turner SR; Strohbach JW; Tommasi RA; Johnson PD; Aristoff PA; Judge TM; Gammill RB; Morris JK; Romines KR; Chrusciel RA; Hinshaw RR; Chong KT; Tarpley WG; Poppe SM; Slade DE; Lynn JC; Horng MM; Tomich PK; Seest EP; Dolak LA; Howe WJ; Howard GM; Watenpaugh KD
J Med Chem; 1996 Oct; 39(22):4349-53. PubMed ID: 8893827
[No Abstract] [Full Text] [Related]
28. Antiretroviral agents as inhibitors of both human immunodeficiency virus type 1 integrase and protease.
Mazumder A; Wang S; Neamati N; Nicklaus M; Sunder S; Chen J; Milne GW; Rice WG; Burke TR; Pommier Y
J Med Chem; 1996 Jun; 39(13):2472-81. PubMed ID: 8691444
[TBL] [Abstract][Full Text] [Related]
29. Unique thermodynamic response of tipranavir to human immunodeficiency virus type 1 protease drug resistance mutations.
Muzammil S; Armstrong AA; Kang LW; Jakalian A; Bonneau PR; Schmelmer V; Amzel LM; Freire E
J Virol; 2007 May; 81(10):5144-54. PubMed ID: 17360759
[TBL] [Abstract][Full Text] [Related]
30. Design and synthesis of highly potent HIV-1 protease inhibitors with novel isosorbide-derived P2 ligands.
Qiu X; Zhao GD; Tang LQ; Liu ZP
Bioorg Med Chem Lett; 2014 Jun; 24(11):2465-8. PubMed ID: 24767846
[TBL] [Abstract][Full Text] [Related]
31. Design and synthesis of HIV protease inhibitors containing allophenylnorstatine as a transition-state mimic.
Kiso Y
Adv Exp Med Biol; 1995; 362():413-23. PubMed ID: 8540352
[No Abstract] [Full Text] [Related]
32. A quantitative structure-activity relationship study on some sulfolanes and arylthiomethanes acting as HIV-1 protease inhibitors.
Gupta SP; Babu MS; Sowmya S
Bioorg Med Chem; 1998 Nov; 6(11):2185-92. PubMed ID: 9881109
[TBL] [Abstract][Full Text] [Related]
33. Nonpeptidal P2 ligands for HIV protease inhibitors: structure-based design, synthesis, and biological evaluation.
Ghosh AK; Kincaid JF; Walters DE; Chen Y; Chaudhuri NC; Thompson WJ; Culberson C; Fitzgerald PM; Lee HY; McKee SP; Munson PM; Duong TT; Darke PL; Zugay JA; Schleif WA; Axel MG; Lin J; Huff JR
J Med Chem; 1996 Aug; 39(17):3278-90. PubMed ID: 8765511
[TBL] [Abstract][Full Text] [Related]
34. Structure of a non-peptide inhibitor complexed with HIV-1 protease. Developing a cycle of structure-based drug design.
Rutenber E; Fauman EB; Keenan RJ; Fong S; Furth PS; Ortiz de Montellano PR; Meng E; Kuntz ID; DeCamp DL; Salto R
J Biol Chem; 1993 Jul; 268(21):15343-6. PubMed ID: 8340363
[TBL] [Abstract][Full Text] [Related]
35. New active HIV-1 protease inhibitors derived from 3-hexanol: conformation study of the free inhibitors in crystalline state and in complex with the enzyme.
Ziółkowska NE; Bujacz A; Randad RS; Erickson JW; Skálová T; Hašek J; Bujacz G
Chem Biol Drug Des; 2012 May; 79(5):798-809. PubMed ID: 22296826
[TBL] [Abstract][Full Text] [Related]
36. Quantitative structure-activity relationships of some HIV-protease inhibitors.
Gupta SP; Babu MS; Kaw N
J Enzyme Inhib; 1999; 14(2):109-23. PubMed ID: 10445038
[TBL] [Abstract][Full Text] [Related]
37. Advances in non-peptidomimetic HIV protease inhibitors.
Pang X; Liu Z; Zhai G
Curr Med Chem; 2014 Jun; 21(17):1997-2011. PubMed ID: 24533811
[TBL] [Abstract][Full Text] [Related]
38. Structure-based design, synthesis, X-ray studies, and biological evaluation of novel HIV-1 protease inhibitors containing isophthalamide-derived P2-ligands.
Ghosh AK; Takayama J; Kassekert LA; Ella-Menye JR; Yashchuk S; Agniswamy J; Wang YF; Aoki M; Amano M; Weber IT; Mitsuya H
Bioorg Med Chem Lett; 2015 Nov; 25(21):4903-4909. PubMed ID: 26096678
[TBL] [Abstract][Full Text] [Related]
39. Use of medium-sized cycloalkyl rings to enhance secondary binding: discovery of a new class of human immunodeficiency virus (HIV) protease inhibitors.
Romines KR; Watenpaugh KD; Tomich PK; Howe WJ; Morris JK; Lovasz KD; Mulichak AM; Finzel BC; Lynn JC; Horng MM
J Med Chem; 1995 May; 38(11):1884-91. PubMed ID: 7783120
[TBL] [Abstract][Full Text] [Related]
40. [Effect of S-oxidation on the anticoagulant effects of 4-hydroxycoumarins, 4-hydroxy-2-pyrones and 1,3-indanediones].
Rehse K; Rüther D
Arch Pharm (Weinheim); 1984 Mar; 317(3):262-7. PubMed ID: 6732447
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
